When Chasing COVID-19 Market Opportunities, Watch For Regulatory Hurdles
Executive Summary
Companies offering OTC sample collection kits to help diagnose COVID-19 quickly fell under scrutiny in the US because the FDA hasn’t authorized any OTC tests.
You may also be interested in...
Everlywell Raises $175M To Expand Consumer Lab Testing, Digital Health
The series D financing will support the expansion of Everlywell’s consumer lab testing and digital health businesses.
Everlywell Launches ‘At Home’ COVID-19 Test Collection Kit
The Texas company is planning to sell 30,000 at-home sample collection kits for COVID-19 testing beginning on 23 March.
Bogus Coronavirus Claims For Silver, Essential Oils, Herbalist's Tea 'Protocol' Plus A Price Discount
Obviously unsubstantiated claims on how the products either prevent or cure the virus didn’t escape FDA and FTC's attention -- they warned seven firms attempting to capitalize on consumer fears. They warnings are the “first step” and they plan to enforce action against companies that continue to market products with treatment claims.